Skip Navigation
Skip to contents

ICDM 2021

Corporate symposia

Satellite symposium 1 LIVE Channel A 12:20~12:40 / Friday 8 October
LIVE Channel A
Chairman:Moon-Kyu Lee
Sung Wan Chun
Soonchunhyang University, Korea
 SS1 Individualized T2DM treatment focus on recent treatment option
Satellite symposium 2 LIVE Channel B 12:20~12:40 / Friday 8 October
LIVE Channel B
Chairman:Yong-Wook Cho
Sung Hoon Yu
Hanyang University, Korea
 SS2 Cardiovascular outcome study of evogliptin: A nationwide cohort study
Satellite symposium 3 LIVE Channel C 12:20~12:40 / Friday 8 October
LIVE Channel C
Chairman:In-Kyu Lee
Sin Gon Kim
Korea University, Korea
 SS3 Life-changing cardiorenal protection; a holistic approach by SGLT2 inhibitor in type 2 diabetes
Satellite symposium 4 LIVE Channel D 12:20~12:40 / Friday 8 October
LIVE Channel D
Chairman:Jaemyung Yu
Tae Jung Oh
Seoul National University, Korea
 SS4 A view beyond HbA1c: clinical implication of glycemic variability & time in range as a new parameter
Satellite symposium 5 LIVE Channel A 08:30~08:50 / Saturday 9 October
LIVE Channel A
Chairman:Cheol-Young Park
Jae-Han Jeon
Kyungpook National University, Korea
 SS5 Expanding the spectrum of SGLT2i endocrinology's initiatives
Satellite symposium 6 LIVE Channel B 08:30~08:50 / Saturday 9 October
LIVE Channel B
Chairman:In Joo Kim
Sung Hee Choi
Seoul National University, Korea
 SS6 Optimal treatment for DM patients with dyslipidemia
Satellite symposium 7 LIVE Channel C 08:30~08:50 / Saturday 9 October
LIVE Channel C
Chairman:Kyung Wan Min
Changhee Jung
University of Ulsan, Korea
 SS7 Rationale and options for early combination therapy in treatment of T2D
Satellite symposium 8 LIVE Channel D 08:30~08:50 / Saturday 9 October
LIVE Channel D
Chairman:Dae Ho Lee
Hye Soon Kim
Keimyung University, Korea
 SS8 Why sulfonylureas remain a cornerstone : Importance of glycemic control in type 2 diabetes treatment
Satellite symposium 9 LIVE Channel A 12:20~12:40 / Saturday 9 October
LIVE Channel A
Chairman:Kwan Woo Lee
Silvio Inzucchi
Yale School of Medicine, USA
SS9 SGLT2 inhibitors in T2D: when should treatment be initiated?
Satellite symposium 10 LIVE Channel B 12:20~12:40 / Saturday 9 October
LIVE Channel B
Chairman:Kyung Ah Han
Sunghwan Suh
Dong-A University, Korea
 SS10 Optimal T2D management in Korean elderly patients
Satellite symposium 11 LIVE Channel C 12:20~12:40 / Saturday 9 October
LIVE Channel C
Chairman:Ho Sang Shon
Jun Hwa Hong
Eulji University, Korea
 SS11 Treatment benefit of TZD based on evidence for Korean T2DM
Korean Diabetes Association
(04146) 101-2104, Lotte Castle President, 109 Mapo-gu, Seoul, Korea

E-mail : icdm@diabetes.or.kr

Congress Secretariat (People & Value, Inc)
A-1108, Doosan The Land Park, 161-8 Magokjungang-ro Gangseo-gu, Seoul, Korea
  • Korean Diabetes Association
  • 당뇨병학연구재단
  • dmj